We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, [...]
ResoTher Pharma profiled in MedWatch
Today ResoTher Pharma was profiled by the prominent Danish biotech [...]
ResoTher Pharma wins prestigious Merck Advance Biotech Grant Award
ResoTher Pharma is extremely pleased to announce our nomination as [...]
Latest News
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, [...]
ResoTher Pharma profiled in MedWatch
Today ResoTher Pharma was profiled by the prominent Danish biotech [...]
ResoTher Pharma wins prestigious Merck Advance Biotech Grant Award
ResoTher Pharma is extremely pleased to announce our nomination as [...]
